other following agendas, deemed as if the consideration and approval on the matters in Agenda 3 to Agenda 9 is not approved by the shareholders’ meeting. In this regard, the date to determine list of
approval on the matters in Agenda 3 to Agenda 9 is not approved by the shareholders’ meeting. In this regard, the date to determine list of shareholders who are entitled to attend the Extraordinary General
Commission Notification of the Office of the Securities and Exchange Commission No. OrThor/Nor/Khor. 11/2548 Re: Practical Guideline on Application for Approval and Approval for Appointment of an Executive of
Office of the Securities and Exchange Commission No. OrThor/Nor/Khor. 11/2548 Re: Practical Guideline on Application for Approval and Approval for Appointment of an Executive of a Derivatives Business
and Exchange Commission Notification of the Office of the Securities and Exchange Commission No. OrThor/Nor/Khor. 11/2548 Re: Practical Guideline on Application for Approval and Approval for Appointment
; however, the rights to receive the dividends remain uncertain as it requires the prior approval from the 2018 Annual General Meeting of Shareholders and any shareholders who are disqualified to receive
securities business, having obtained an approval to establish from and having registered [such establishment] with the SEC Office; (2) an association relating to supervision of a derivatives intermediary, of
Procedures for Approval of the Private Fund Custodian 22/12/2004 16/12/2004 4. Notification of Capital Market Supervisory Board 85/2552 03/08/2009 01/09/2009 5. Notification of Capital Market
accounting and approval of the disposal of investmentsBS Myco Biotech Company Limited ( 2 st review) 28/12/2021 19:33 Notification of the resignation of the Company's director and appointment of a supervisor
(effective on 1 January 2018). 2 “association” means: (1) an association relating to a securities business, of which objectives is for promoting and developing securities business, having obtained an approval